ALNY Alnylam Pharmaceuticals

Healthcare Biotechnology

Latest news and analysis for Alnylam Pharmaceuticals (ALNY).

2 articles | Category: Healthcare

Current Price

$332.92 +1.68 (0.51%)

Market data may be delayed

Price Chart

Loading chart...

All Articles for ALNY

Healthcare | ALNY | 4d ago

Behind ALNY's Big Move: Frontier Pact Adds Genetic Drug Optionality

ALNY has announced a pivotal partnership with Frontier Pact, enhancing its genetic drug offerings. This could significantly impact ALNY's market trajectory.

Healthcare | ALNY | 2w ago

Alnylam Pharmaceuticals Price Target Cut Sparks Debate Over ALNY

Bank of America has revised its price target for Alnylam Pharmaceuticals to $462. What does this mean for ALNY investors?

Related Stocks in Healthcare

LLY

Eli Lilly 6 articles

PFE

Pfizer Inc. 3 articles

VRTX

Vertex Pharmaceuticals 3 articles

RARE

Ultragenyx Pharmaceutical 3 articles

NVO

Novo Nordisk 3 articles

HIMS

Hims & Hers Health 3 articles

JNJ

Johnson & Johnson 2 articles

GILD

Gilead Sciences 2 articles

SYK

Stryker Corp. 2 articles

REGN

Regeneron Pharmaceuticals 2 articles

ELV

Elevance Health 2 articles

HUM

Humana Inc. 2 articles

Cookie Notice